Skip to main content

Table 5 Discordant HPV test results resolved by their HPV genotype detected by INNO-LiPA genotyping

From: A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

HPV genotype

HPV classification

HR HC2-ve, CER+ve (N)

CER-ve, HR HC2+ve (N)

Histology CIN2+ (HC2-ve/CER-ve)

HPV16*

HR

4

4

0/2

HPV18*

HR

0

1

0/1

HPV31*

HR

0

3

0

HPV33*

HR

0

1

0

HPV39*

HR

1

1

0

HPV51*

HR

1

6

0

HPV52*

HR

1

4

0

HPV66**

HR

2

1

0

HPV68*

Intermediate

0

2

0

HPV53

Intermediate

1

11

0

HPV6

LR

0

1

0

HPV54

LR

0

1

0

HPV69/71

LR

1

0

0

HPV74

LR

1

1

0

HPVX

 

2

2

0

HPV DNA negative

 

56

3

0

no result (sample failed)

 

19

2

0

Total

 

89

44

3

  1. *HC2 and Cervista target types; **Cervista target type; HPVX: HPV DNA was detected by LiPA, but could not be correlated to a specific type; +ve: positive; −ve: negative.